# Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors

> **NCT00618735** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 68 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** BIIB021
- **DRUG:** BIIB021

## Key facts

- **NCT ID:** NCT00618735
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2010-07
- **Final completion:** 2010-12
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2016-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00618735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00618735, "Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00618735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*